Therapeutics

Developing drugs that target novel biological pathways

Learn More

Bioprocessing

Products to enhance manufacturing efficiency and economics

Learn MoreOrder Now

Highlights

  • Aug 31, 2010:   Repligen to Present at the Rodman & Renshaw Annual Global Investment Conference Monday, September 13th, 12:05 p.m. EDT   More
  • Aug 05, 2010:   Repligen Reports First Quarter Fiscal Year 2011 Financial Results Product Sales Increase by 73%   More
  • Aug 02, 2010:   Repligen Receives Additional Research Grants to Support Development of HDAC Inhibitors for Friedreich’s Ataxia and Huntington’s Disease   More